We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 154

The Indian medical device industry - regulatory, legal and tax overview

  • Nishith Desai Associates
  • -
  • India
  • -
  • March 19 2015

The Indian medical devices sector is worth approximately USD 3 Billion and is growing at a CAGR of 15. The medical devices market in India is

India

  • Krishna & Saurastri Associates
  • -
  • India
  • -
  • February 13 2015

The manufacture, distribution, labelling, packaging, sale or stocking of any drug in India is regulated by the Drugs and Cosmetics Act 1940. Under the

Delhi High Court sets aside Patent Office order rejecting Gilead’s patent application for Hepatitis C drug Solvadi on procedural grounds

  • Khaitan & Co
  • -
  • India
  • -
  • February 4 2015

On 30 January 2015, the Delhi High Court set aside an order dated 13 January 2015 (Order) of the Indian Patent Office (IPO) rejecting a patent to

Update on India - January 2015

  • CMS Cameron McKenna
  • -
  • India
  • -
  • January 23 2015

In line with the Government of India’s (the “government”) general policy, it has over the last six months introduced a number of measures to

Gilead’s Sovaldi fails “enhancement of known efficacy” test in India

  • RNA, Intellectual Property Attorneys
  • -
  • India
  • -
  • January 19 2015

The Indian Patent Office in its latest ruling of 13th January 2015 rejected the patent application by Gilead, covering important metabolites for its

Court resolves Pudin Hara advertising dispute

  • Lakshmikumaran & Sridharan
  • -
  • India
  • -
  • December 17 2014

Consumers may have noticed several Indian advertisements relating to antacids and other medicines that cure heartburn and gastric problems. Recently

Compulsory license granted for Nexavar to continue, holds Supreme Court

  • Khaitan & Co
  • -
  • India
  • -
  • December 15 2014

In an order dated 12 December 2014, the Supreme Court (SC) has dismissed Bayer's Special Leave Petition filed against the order of Bombay High Court

Ranbaxy loses FDA approval for two generics

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA

Healthcarepharmaceutical update

  • Clyde & Co LLP
  • -
  • India
  • -
  • October 28 2014

Sometime in May 2013, the Department of Pharmaceuticals, part of the Ministry of Chemicals and Fertilizers, Govt. Of India, released a Drug Price

International Non-Proprietary Names as trademarks in India INN or out?

  • Selvam and Selvam
  • -
  • India
  • -
  • October 14 2014

International Non-Proprietary Names (INN) are globally recognized names for pharmaceutical substances or active pharmaceutical ingredients and are